Levonorgestrel-releasing intrauterine system versus endometrial ablation for heavy menstrual bleeding

Autor: Jan Willem van der Steeg, Diana S. Massop-Helmink, Lucet F. van der Voet, Patrick M. M. Bossuyt, Heleen P. Eising, Pleun Beelen, Theodoor E. Nieboer, Janny H. Dekker, Sjors F.P.J. Coppus, Ruben G. Duijnhoven, Marlies Y. Bongers, Ellen R. Klinkert, Marjolein Y. Berger, Marian J van den Brink, Anne Timmermans, Joke M. Schutte, Nienke Mak, Nicol A. C. Smeets, Peggy M.A.J. Geomini, Sebastiaan Veersema, Malou C. Herman, Marchien van Baal, Ben W.J. Mol, Hannah S. van Meurs

Publikováno v: American journal of obstetrics and gynecology, 224(2), 187.e1-187.e10. Mosby Inc.
American Journal of Obstetrics and Gynecology, 224
American Journal of Obstetrics and Gynecology, 224(2), 187.e1-187.e10. MOSBY-ELSEVIER
American Journal of Obstetrics and Gynecology, 224(2). MOSBY-ELSEVIER
American Journal of Obstetrics and Gynecology, 224, 2

Heavy menstrual bleeding (HMB) can negatively influence physical activity, work productivity, and sexual life and therefore has a major impact on women's quality of life (QoL). The National Institute for Health and Care Excellence guidelines recommen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::664ed54c6acb5551da2375c3aaf41944
https://doi.org/10.1016/j.ajog.2020.08.016